Filing Details

Accession Number:
0001209191-16-091135
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-13 14:36:09
Reporting Period:
2016-01-11
Filing Date:
2016-01-13
Accepted Time:
2016-01-13 14:36:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
819050 Vical Inc VICL Biological Products, (No Disgnostic Substances) (2836) 930948554
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198238 B Vijay Samant 10390 Pacific Center Court
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock $.01 Par Value Disposition 2016-01-11 48,535 $0.35 1,018,028 No 4 S Direct
Common Stock $.01 Par Value Disposition 2016-01-12 11,202 $0.35 1,006,826 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sale of 48,535 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on February 25, 2014.
  2. Represents a weighted average sales price per share. The prices actually received ranged from $0.34 to $0.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Sale of 11,202 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on February 25, 2014.
  4. Represents a weighted average sales price per share. The prices actually received ranged from $0.3410 to $0.3599. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. This balance includes 431,139 unvested shares subject to restricted stock units.